OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
Nantes and Paris - France, January 29, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) and Scienta Lab, a leader in Artificial Intelligence (AI)-driven precision immunology, announce a strategic collaboration to harness Scienta Lab's advanced AI platform for modeling inflammatory diseases and identifying predictive biomarkers of efficacy for immunotherapies.
Under this agreement, Scienta Lab will deploy EVA, its proprietary AI-powered multimodal foundation model dedicated to translational research in immunology, to discover multimodal signatures that can pinpoint predictive biomarkers for immunotherapy in immuno-inflammation. The aim is to identify patient subtypes likely to respond to specific therapeutic options and extract associated multimodal biomarkers through explainable AI. This initiative represents a significant step in precision medicine, supporting the development of tailored immunotherapies that drive better outcomes for patients with immune-mediated inflammatory diseases.
Camille Bouget, CEO and Co-founder of Scienta Lab, stated: "Given the complex and heterogeneous nature of immuno-inflammatory pathologies, precisely targeted therapeutic interventions are essential for achieving optimal patient outcomes. We are very pleased to partner with OSE Immunotherapeutics, a leading European biotech, to leverage EVA in pursuit of this objective. Our aim is to uncover multimodal signatures that integrate systemic and local factors to stratify immuno-inflammatory diseases into distinct subtypes. The partnership is set to generate significant scientific and economic value for both companies while advancing our shared mission of driving innovation in precision immunology.'
Nicolas Poirier, CEO of OSE Immunotherapeutics, commented: "We are excited about this new collaboration as we continually seek to integrate pioneering AI approaches and technologies to develop first-in-class products in immuno-oncology and immuno-inflammation. In today's fast-paced world, speed is the new currency, and an AI solution capable of identifying predictive biomarkers in immuno-inflammation will be pivotal in our research and clinical development efforts across various chronic inflammatory and autoimmune diseases. This partnership could help speed up our innovation process, potentially leading to more personalized treatments that greatly improve patient health and quality of life.'
This collaboration builds on OSE Immunotherapeutics' commitment to integrating AI solutions that enhance the Company's research and development efforts. In 2020, OSE Immunotherapeutics entered into agreement with MAbSilico to utilize AI technology for the design and discovery of antibody drugs. This ongoing partnership aims to aid and speed-up therapeutic antibody discovery, reduce the risk of failure, and expedite preclinical development.
ABOUT SCIENTA LAB
Scienta Lab is a deeptech company harnessing artificial intelligence to pioneer AI-powered Precision Immunology. With its unique and proprietary technology based on a foundation model, Scienta Lab leverages multimodal data to support translational research and clinical development in immuno-inflammation. Scienta Lab research activities, led in partnership with top-tier academic institutions, pharmaceutical and biotech companies, are regularly featured in medical journals and international congresses. For more information, visit https://www.scientalab.com.
Contact
Camille Bougetcamille.bouget@scientalab.comABOUT OSE IMMUNOTHERAPEUTICS
OSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs of today and tomorrow. We partner with leading academic institutions and biopharmaceutical companies in our efforts to develop and bring to the market transformative medicines for people with serious diseases. OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext.Additional information about OSE Immunotherapeutics assets is available on the Company's website: www.ose-immuno.com.Contacts
Fiona Olivierfiona.olivier@ose-immuno.comSylvie Détrysylvie.detry@ose-immuno.com
French Media Contact FP2COMFlorence Portejoiefportejoie@fp2com.fr+33 6 07 768 283U.S. Media ContactRooney Partners LLCKate Barrettekbarrette@rooneypartners.com+1 212 223 0561
Forward-looking statementsThis press release contains express or implied information and statements that might be deemed forward-looking information and statements in respect of OSE Immunotherapeutics. They do not constitute historical facts. These information and statements include financial projections that are based upon certain assumptions and assessments made by OSE Immunotherapeutics' management considering its experience and its perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements include statements typically using conditional and containing verbs such as 'expect', 'anticipate', 'believe', 'target', 'plan', or 'estimate', their declensions and conjugations and words of similar import. Although the OSE Immunotherapeutics management believes that the forward-looking statements and information are reasonable, the OSE Immunotherapeutics' shareholders and other investors are cautioned that the completion of such expectations is by nature subject to various risks, known or not, and uncertainties which are difficult to predict and generally beyond the control of OSE Immunotherapeutics. These risks could cause actual results and developments to differ materially from those expressed in or implied or projected by the forward-looking statements. These risks include those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future performance. This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on April 30, 2024, including the annual financial report for the fiscal year 2023, available on the OSE Immunotherapeutics' website. Other than as required by applicable law, OSE Immunotherapeutics issues this press release at the date hereof and does not undertake any obligation to update or revise the forward-looking information or statements.
Attachment
EN_250129_OSE_Scienta Lab_vf
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
38 minutes ago
Asian shares mostly gain as eyes turn to meetings at the White House and Jackson Hole
BANGKOK -- Asian shares were mostly higher Monday after the S&P 500 and Nasdaq composite edged back from their record levels while the Dow inched to a new record close. U.S. futures were little changed as investors watched for developments in the Ukraine crisis following a summit between President Donald Trump and Russian President Vladimir Putin that brought no breakthroughs. Japan's Nikkei 225 gained 0.8% to 43.714.31, while the Hang Seng in Hong Kong added 0.1% to 25,291.42. The Shanghai Composite index jumped 1% to 3,732.44. Australia's S&P/ASX 200 picked up 0.2% to 8,959.30. The Kospi in South Korea declined 1.5% to 3,177.28 on heavy selling of semiconductor makers like Samsung Electronics, whose shares fell 2.2%. SK Hynix lost 3.3% as investors fretted over the possibility of more U.S. tariffs on computer chips. Trump was preparing to meet later Monday with Ukrainian President Volodymyr Zelenskyy and other European leaders in Washington. The European vanguard were not included in Trump's summit with Russian President Vladimir Putin last Friday. They are seeking to present a united front in safeguarding Ukraine and the continent from any widening aggression from Moscow. An annual meeting in Jackson Hole, Wyoming, of top central bankers later this week will be watched closely for hints about possible interest rate cuts from Federal Reserve chair Jerome Powell. He is due to speak Friday at the economic policy conference. 'While the official theme is labor markets, investors will scrutinize any hint of September policy direction, especially after last week's mixed inflation data,' Ipek Ozkardeskaya of Swissquote said in a commentary, adding that 'any progress on Ukraine peace talks could push global equities higher still.' Expectations have been building that the Fed will cut interest rates at its next meeting in September, though mixed reports on the U.S. economy have undercut those bets somewhat. One report Friday said shoppers boosted their spending at U.S. retailers last month, while another said manufacturing in New York state unexpectedly grew. A third said industrial production across the country shrank last month, when economists were looking for modest growth. Yet another report suggested sentiment among U.S. consumers is worsening because of worries about inflation, when economists expected to see a slight improvement. On Wall Street, UnitedHealth Group jumped 12% on Friday after famed investor Warren Buffett's Berkshire Hathaway said it bought nearly 5 million shares of the insurer during the spring, valued at $1.57 billion. Buffett is known for trying to buy good stocks at affordable prices, and UnitedHealth's halved for the year by the end of July because of a run of struggles. Berkshire Hathaway's own stock slipped 0.4%. Applied Materials helped lead Wall Street lower with a decline of 14.1% even though it reported better results for the latest quarter than analysts expected. The focus was on the company's forecast for a drop in revenue during the current quarter. Its products help manufacture semiconductors and advanced displays, and CEO Gary Dickerson pointed to a 'dynamic macroeconomic and policy environment, which is creating increased uncertainty and lower visibility in the near term, including for our China business.' Sandisk fell 4.6% despite reporting a profit for the latest quarter that blew past analysts' expectations. Investors focused instead on the data storage company's forecast for profit in the current quarter, which came up short of Wall Street's. On Friday, the S&P 500 fell 0.3%. The Dow Jones Industrial Average edged 0.1% higher. The Nasdaq composite sank 0.4%. In other dealings early Monday, U.S. benchmark crude oil rose 24 cents to $63.04 per barrel, while Brent crude, the international standard, climbed 16 cents to $66.01 per barrel.
Business Wire
an hour ago
- Business Wire
euNetworks Achieves a Sustainability ‘A' Grade in CDP's Supplier Engagement Assessment
LONDON,--(BUSINESS WIRE)--euNetworks Group Limited ('euNetworks'), a European critical bandwidth infrastructure company, has today announced it has been awarded an 'A' grade by environmental reporting organisation CDP (Carbon Disclosure Project) for the 2024 disclosure cycle of their Supplier Engagement Assessment (SEA). The A grade is the highest score that can be attained in the SEA and is awarded to organisations that demonstrate leadership and best practice in driving environmental changes in their supply chain. Sustainability is deeply embedded in euNetworks' business strategy, and engaging with our suppliers to ensure we are reducing our Scope 3 emissions is crucial to ensuring we drive decarbonisation beyond our own direct operations. Share Organisations are assessed on a number of criteria relating to how they engage with their suppliers on Risk Management, Governance & Business, Scope 3 emissions and Targets. To attain an A grade, organisations must rank highly across all categories, demonstrating a fully integrated approach to reducing emissions throughout their supply chain. The achievement is a key milestone in euNetworks' ongoing commitment to sustainability. The company is a signatory to the Climate Pledge - a cross-sector initiative founded by Amazon and Global Optimism that brings together leading global companies committed to addressing the climate crisis and accelerating the decarbonisation of the economy. As part of this commitment, the company has pledged to reach net-zero carbon emissions by 2040, and has set science-based targets aligned with the 1.5°C pathway across Scopes 1, 2, and 3. As well as engaging with its suppliers to implement more sustainable practices, euNetworks has developed award-winning Carbon By Service and Network Construction Carbon calculators, enabling its customers to access emissions reporting based on their euNetworks services and network projects. Marisa Trisolino, CEO at euNetworks, said: 'We are proud to have been awarded this ranking by the CDP, which reflects our dedication and leadership in reducing carbon emissions across our supply chain. Sustainability is deeply embedded in euNetworks' business strategy, and engaging with our suppliers to ensure we are reducing our Scope 3 emissions is crucial to ensuring we drive decarbonisation beyond our own direct operations.' Trisolino continued: 'Collaborating with our suppliers, customers and partners is key to driving true environmental progress, and we will continue to build on the momentum we have gained through our sustainability practices so far to forge a greener future for our entire value chain.' About euNetworks euNetworks is a critical bandwidth infrastructure company. We own and operate 18 fibre based metropolitan networks connected with a high-capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 574 today, and is also a leading cloud connectivity provider, with over 180 on-ramps on our network directly connecting all key cloud providers and major platforms. This coupled with our extensive connected data centre footprint positions us strongly to support and enable our Customers with their cloud infrastructure developments and challenges. We offer a targeted portfolio of metropolitan and long-haul services across our network platform and Super Highways, including Dark Fibre, Wavelengths, and Ethernet. Wholesale, Finance, Content, Media, Mobile, Data Centre, Hyperscale and Enterprise customers benefit from euNetworks' unique inventory of fibre and duct-based assets that are tailored to fulfil their high bandwidth needs. euNetworks delivers services with an active commitment to sustainability, striving towards net-zero carbon emissions, promoting environmentally responsible supply chain practices, and engaging collaboratively with the industry to address the environmental challenges ahead. For further information visit
Yahoo
2 hours ago
- Yahoo
Oil Gains as Focus Shifts to Zelenskiy Meet After Alaska Summit
(Bloomberg) -- Oil rose as investors turned their attention to Donald Trump's meeting with Volodymyr Zelenskiy on Monday, with the Ukrainian leader facing US pressure to reach a peace deal with Russia that involves ceding territory. The US-Canadian Road Safety Gap Is Getting Wider A Photographer's Pipe Dream: Capturing New York's Vast Water System Festivals and Parades Are Canceled Amid US Immigration Anxiety A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Princeton Plans New Budget Cuts as Pressure From Trump Builds Brent traded near $66 a barrel after closing 1.5% lower in the previous session, while West Texas Intermediate was above $63. In a show of support, European leaders including European Commission President Ursula von der Leyen, French President Emmanuel Macron, and NATO Secretary-General Mark Rutte, will join the high-stakes meeting in Washington with Trump and Zelenskiy. The US president said after his talks with Vladimir Putin in Alaska on Friday that he'll urge Zelenskiy to make a quick deal, and sounded receptive to the Russian leader's demand that Ukraine give up large swathes of land. 'We're still a long ways off,' Secretary of State Marco Rubio, who took part in the summit, told Fox News on Sunday. 'We are not at the precipice of a peace agreement. We are not at the edge of one. But I do think progress was made.' Trump told European leaders after the meeting that the US could contribute to any security guarantees, and that Putin was prepared to accept that. However, it remains unclear what kind of guarantees are being discussed with the Russian leader, and what the Kremlin is willing to accept. In a Truth Social post late Sunday, Trump said Zelenskiy 'can end the war with Russia almost immediately, if he wants to, or he can continue to fight.' He also made a reference to Crimea, without providing further details. Prior to the summit in Alaska, Trump told allies that reaching a ceasefire would be his key demand, and threatened to walk out of the talks and impose tough new measures on Moscow and countries buying its oil if it wasn't met. On Friday, the US president signaled he was in no hurry to implement penalties. So far, Trump has singled out India for buying Russian crude, slapping the South Asian nation with hefty tariffs for doing so. However, the US president said in a Fox News interview on Friday that he will hold off increasing levies on Chinese goods due to the country's purchases of Moscow's crude. 'The fact that further meetings are taking place here is a positive,' said Robert Rennie, the head of commodity and carbon research at Westpac Banking Corp. Talks around seeking a resolution to the Ukraine war have injected uncertainty into the market, and led to oil trading in a narrow range recently. Still, futures are down more than 10% this year on concerns around the fallout from Trump's trade policies and as OPEC+ rapidly returns idled barrels to the market. What Declining Cardboard Box Sales Tell Us About the US Economy Americans Are Getting Priced Out of Homeownership at Record Rates Living With 12 Strangers to Ease a Housing Crunch Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan How Syrian Immigrants Are Boosting Germany's Economy ©2025 Bloomberg L.P. 登入存取你的投資組合
